SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John H. Farro who wrote (4255)8/13/1999 4:44:00 PM
From: Jonathan Schonsheck   of 4342
 
The Company has initiated testing for several raw material suppliers and
finished goods manufactures. Revenues derived from testing are increasing and
the Company expects that requests for testing will continue to increase in the
coming months as the industry enters its peak selling period from September to
March. The Company is also in active discussions with several sellers of
finished dietary supplements and sellers of raw materials and expects to
complete negotiations shortly that will result in BioFIT (TM) certified products
being seen on store shelves later this year.
The Company is also continuing its efforts to expand the scope of the BioFIT
(TM) program to the rest of the world and is in ongoing discussions with R.P.
Scherer pursuant to a letter agreement signed in March 1999 to take advantage of
this opportunity.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News